Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases	Neoplasms by Site, central nervous system cancer, neoplasm, neoplastic meningitis, nervous system disorder, non-small cell lung carcinoma, tumor of meninges	Recruiting	Phase 4	2025-07-29		NCT07092202

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Wuhan Union Hospital	Wuhan	China	32

Clinical trials